City Therapeutics Inc.

Status: Publicly traded

Last reviewed: November 2026

Direct answer

City Therapeutics Inc. is publicly traded on NASDAQ under the ticker CTY.

City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets. Its R&D pipeline includes programs addressing...

Can you invest in City Therapeutics Inc.?

Yes. City Therapeutics Inc. is publicly traded on NASDAQ under the ticker CTY.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for City Therapeutics Inc.

Detailed equity research is provided by MarketSnap.